Herpes simplex virus has been extensively genetically modified for gene tra
nsfer to nerve and other tissues, to create vectors that are devoid of vira
l gene expression and toxicity. Recombinant vectors have been engineered to
express genes which protect neurons against toxic insults resulting in cel
l death, including nerve growth factor (NGF) and anti-apopiotic genes (eg b
cl-2). This review describes experiments using HSV vectors expressing these
gene products and their potential protective role in ameliorating neurodeg
enerative processes in animal model systems.